Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
Identifieur interne : 000255 ( Main/Exploration ); précédent : 000254; suivant : 000256Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
Auteurs : Merle M. Böhmer [Allemagne] ; Dietmar Walter ; Gerhard Falkenhorst ; Stephan Müters ; Gérard Krause ; Ole WichmannSource :
- BMC public health [ 1471-2458 ] ; 2012.
Descripteurs français
- KwdFr :
- Accessibilité des services de santé, Adolescent, Adulte, Adulte d'âge moyen, Allemagne (épidémiologie), Enquêtes sur les soins de santé, Femelle, Grippe humaine (), Grippe humaine (épidémiologie), Humains, Jeune adulte, Mâle, Pandémies (), Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Vaccins antigrippaux (administration et posologie), Études de suivi.
- MESH :
- administration et posologie : Vaccins antigrippaux.
- épidémiologie : Allemagne, Grippe humaine.
- Accessibilité des services de santé, Adolescent, Adulte, Adulte d'âge moyen, Enquêtes sur les soins de santé, Femelle, Grippe humaine, Humains, Jeune adulte, Mâle, Pandémies, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de suivi.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Germany (epidemiology), Health Care Surveys, Health Services Accessibility, Humans, Influenza Vaccines (administration & dosage), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Male, Middle Aged, Pandemics (prevention & control), Seasons, Young Adult.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic , epidemiology : Germany.
- epidemiology : Influenza, Human.
- prevention & control : Influenza, Human, Pandemics.
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Health Care Surveys, Health Services Accessibility, Humans, Male, Middle Aged, Seasons, Young Adult.
Abstract
BACKGROUND
In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.
METHODS
We analysed data from the 'German Health Update' (GEDA10) telephone survey (n=22,050) and a smaller GEDA10-follow-up survey (n=2,493), which were both representative of the general population aged ≥18 years living in Germany.
RESULTS
Overall only 8.8% of the adult population in Germany received a vaccination against pandemic influenza. High socioeconomic status, having received a seasonal influenza shot in the previous season, and belonging to a target group for seasonal influenza vaccination were independently associated with the uptake of pandemic vaccines. The main reasons for not receiving a pandemic vaccination were 'fear of side effects' and the opinion that 'vaccination was not necessary'. Seasonal influenza vaccine uptake in the pre-pandemic season 2008/09 was 52.8% among persons aged ≥60 years; 30.5% among HCW, and 43.3% among chronically ill persons. A decrease in vaccination coverage was observed across all target groups in the first post-pandemic season 2010/11 (50.6%, 25.8%, and 41.0% vaccination coverage, respectively).
CONCLUSIONS
Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination.
DOI: 10.1186/1471-2458-12-938
PubMed: 23113995
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.</title><author><name sortKey="Bohmer, Merle M" sort="Bohmer, Merle M" uniqKey="Bohmer M" first="Merle M" last="Böhmer">Merle M. Böhmer</name><affiliation wicri:level="3"><nlm:affiliation>Immunization Unit, Robert Koch Institute, Berlin, Germany. BoehmerM@rki.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Immunization Unit, Robert Koch Institute, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Walter, Dietmar" sort="Walter, Dietmar" uniqKey="Walter D" first="Dietmar" last="Walter">Dietmar Walter</name></author><author><name sortKey="Falkenhorst, Gerhard" sort="Falkenhorst, Gerhard" uniqKey="Falkenhorst G" first="Gerhard" last="Falkenhorst">Gerhard Falkenhorst</name></author><author><name sortKey="Muters, Stephan" sort="Muters, Stephan" uniqKey="Muters S" first="Stephan" last="Müters">Stephan Müters</name></author><author><name sortKey="Krause, Gerard" sort="Krause, Gerard" uniqKey="Krause G" first="Gérard" last="Krause">Gérard Krause</name></author><author><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:23113995</idno><idno type="pmid">23113995</idno><idno type="doi">10.1186/1471-2458-12-938</idno><idno type="wicri:Area/Main/Corpus">000216</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000216</idno><idno type="wicri:Area/Main/Curation">000216</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000216</idno><idno type="wicri:Area/Main/Exploration">000216</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.</title><author><name sortKey="Bohmer, Merle M" sort="Bohmer, Merle M" uniqKey="Bohmer M" first="Merle M" last="Böhmer">Merle M. Böhmer</name><affiliation wicri:level="3"><nlm:affiliation>Immunization Unit, Robert Koch Institute, Berlin, Germany. BoehmerM@rki.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Immunization Unit, Robert Koch Institute, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Walter, Dietmar" sort="Walter, Dietmar" uniqKey="Walter D" first="Dietmar" last="Walter">Dietmar Walter</name></author><author><name sortKey="Falkenhorst, Gerhard" sort="Falkenhorst, Gerhard" uniqKey="Falkenhorst G" first="Gerhard" last="Falkenhorst">Gerhard Falkenhorst</name></author><author><name sortKey="Muters, Stephan" sort="Muters, Stephan" uniqKey="Muters S" first="Stephan" last="Müters">Stephan Müters</name></author><author><name sortKey="Krause, Gerard" sort="Krause, Gerard" uniqKey="Krause G" first="Gérard" last="Krause">Gérard Krause</name></author><author><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Follow-Up Studies</term><term>Germany (epidemiology)</term><term>Health Care Surveys</term><term>Health Services Accessibility</term><term>Humans</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Male</term><term>Middle Aged</term><term>Pandemics (prevention & control)</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne (épidémiologie)</term><term>Enquêtes sur les soins de santé</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies ()</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Follow-Up Studies</term><term>Health Care Surveys</term><term>Health Services Accessibility</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Seasons</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Accessibilité des services de santé</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Enquêtes sur les soins de santé</term><term>Femelle</term><term>Grippe humaine</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Pandémies</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de suivi</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We analysed data from the 'German Health Update' (GEDA10) telephone survey (n=22,050) and a smaller GEDA10-follow-up survey (n=2,493), which were both representative of the general population aged ≥18 years living in Germany.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Overall only 8.8% of the adult population in Germany received a vaccination against pandemic influenza. High socioeconomic status, having received a seasonal influenza shot in the previous season, and belonging to a target group for seasonal influenza vaccination were independently associated with the uptake of pandemic vaccines. The main reasons for not receiving a pandemic vaccination were 'fear of side effects' and the opinion that 'vaccination was not necessary'. Seasonal influenza vaccine uptake in the pre-pandemic season 2008/09 was 52.8% among persons aged ≥60 years; 30.5% among HCW, and 43.3% among chronically ill persons. A decrease in vaccination coverage was observed across all target groups in the first post-pandemic season 2010/11 (50.6%, 25.8%, and 41.0% vaccination coverage, respectively).</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23113995</PMID><DateCompleted><Year>2013</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2012</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.</ArticleTitle><Pagination><MedlinePgn>938</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1471-2458-12-938</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic influenza A(H1N1)pdm09, which was controversially discussed in the public, was recommended for the whole population. The objectives of this study were to assess vaccination coverage for seasonal (seasons 2008/09-2010/11) and pandemic influenza (season 2009/10), to identify predictors of and barriers to pandemic vaccine uptake and whether the controversial discussions on pandemic vaccination has had a negative impact on seasonal influenza vaccine uptake in Germany.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analysed data from the 'German Health Update' (GEDA10) telephone survey (n=22,050) and a smaller GEDA10-follow-up survey (n=2,493), which were both representative of the general population aged ≥18 years living in Germany.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall only 8.8% of the adult population in Germany received a vaccination against pandemic influenza. High socioeconomic status, having received a seasonal influenza shot in the previous season, and belonging to a target group for seasonal influenza vaccination were independently associated with the uptake of pandemic vaccines. The main reasons for not receiving a pandemic vaccination were 'fear of side effects' and the opinion that 'vaccination was not necessary'. Seasonal influenza vaccine uptake in the pre-pandemic season 2008/09 was 52.8% among persons aged ≥60 years; 30.5% among HCW, and 43.3% among chronically ill persons. A decrease in vaccination coverage was observed across all target groups in the first post-pandemic season 2010/11 (50.6%, 25.8%, and 41.0% vaccination coverage, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Böhmer</LastName><ForeName>Merle M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Immunization Unit, Robert Koch Institute, Berlin, Germany. BoehmerM@rki.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Falkenhorst</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Müters</LastName><ForeName>Stephan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>Gérard</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Wichmann</LastName><ForeName>Ole</ForeName><Initials>O</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006297" MajorTopicYN="Y">Health Services Accessibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23113995</ArticleId><ArticleId IdType="pii">1471-2458-12-938</ArticleId><ArticleId IdType="doi">10.1186/1471-2458-12-938</ArticleId><ArticleId IdType="pmc">PMC3527143</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Infection. 2009 Oct;37(5):390-400</Citation><ArticleIdList><ArticleId IdType="pubmed">19768382</ArticleId></ArticleIdList></Reference><Reference><Citation>Med J Aust. 2010 Jan 4;192(1):33-6</Citation><ArticleIdList><ArticleId IdType="pubmed">20047546</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2010;5(6):e11226</Citation><ArticleIdList><ArticleId IdType="pubmed">20585462</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62</Citation><ArticleIdList><ArticleId IdType="pubmed">20689501</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2010 Sep 7;28 Suppl 4:D3-13</Citation><ArticleIdList><ArticleId IdType="pubmed">20713258</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Public Health. 2010 Oct;20(5):490-4</Citation><ArticleIdList><ArticleId IdType="pubmed">20444821</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1283-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21161479</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Jan 17;29(4):613-4</Citation><ArticleIdList><ArticleId IdType="pubmed">21193121</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2011;11(1):15</Citation><ArticleIdList><ArticleId IdType="pubmed">21211000</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Feb 1;29(6):1332-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21182996</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 May 23;29(23):4008-12</Citation><ArticleIdList><ArticleId IdType="pubmed">21463683</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Jun 15;29(27):4492-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21545822</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Sep 2;29(38):6472-84</Citation><ArticleIdList><ArticleId IdType="pubmed">21756960</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2011 Dec;7(12):1317-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22108034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Feb 1;30(6):995-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22178520</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Feb 8;30(7):1255-64</Citation><ArticleIdList><ArticleId IdType="pubmed">22214889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Mar 23;30(14):2483-9</Citation><ArticleIdList><ArticleId IdType="pubmed">22133511</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012;17(13). pii: 20131</Citation><ArticleIdList><ArticleId IdType="pubmed">22490383</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2011;11:30</Citation><ArticleIdList><ArticleId IdType="pubmed">21226919</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2002 Dec;8(12):1442-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12498661</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 1999 Apr;16(3):173-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10198654</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Mar 24;24(14):2560-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16414160</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2007 Jan;135(1):139-43</Citation><ArticleIdList><ArticleId IdType="pubmed">16740194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 May;52(5):557-70</Citation><ArticleIdList><ArticleId IdType="pubmed">19343279</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 May;53(5):510-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20437020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Berlin</li></region><settlement><li>Berlin</li></settlement></list><tree><noCountry><name sortKey="Falkenhorst, Gerhard" sort="Falkenhorst, Gerhard" uniqKey="Falkenhorst G" first="Gerhard" last="Falkenhorst">Gerhard Falkenhorst</name><name sortKey="Krause, Gerard" sort="Krause, Gerard" uniqKey="Krause G" first="Gérard" last="Krause">Gérard Krause</name><name sortKey="Muters, Stephan" sort="Muters, Stephan" uniqKey="Muters S" first="Stephan" last="Müters">Stephan Müters</name><name sortKey="Walter, Dietmar" sort="Walter, Dietmar" uniqKey="Walter D" first="Dietmar" last="Walter">Dietmar Walter</name><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name></noCountry><country name="Allemagne"><region name="Berlin"><name sortKey="Bohmer, Merle M" sort="Bohmer, Merle M" uniqKey="Bohmer M" first="Merle M" last="Böhmer">Merle M. Böhmer</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000255 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000255 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:23113995
|texte= Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23113995" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |